Trial
NCT06781255
Evaluation of K9 in Subjects With Diabetic Macular Edema (DME)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Michelle Abou-Jaoude
Collaborators
Inflammasome Therapeutics
Condition
Diabetic Macular Edema
Intervention
Kamuvudine-9
Why stopped
Low recruitment outcome
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-06